CUSTODIOL HTK® (Histidine-Tryptophan-Ketoglutarate) is indicated for preservation of multiorgan transplants (heart, kidney, liver, pancreas, lung), together with venous or arterial segments.
CYANOKIT® contains hydroxocobalamin, an antidote indicated for the treatment of known or suspected cyanide poisoning. Cyanokit is to be administered together with appropriate decontamination and supportive measures.
Erythrocin® I.V. (erythromycin lactobionate injection) is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in (1) Lower respiratory tract infections of mild to moderate severity caused by S. pyogenes (Group A beta-hemolytic streptococci), S. pneumoniae and M. pneumoniae; (2) Skin and soft tissue infections of mild to moderate severity caused by S. pyogenes and S. Aureus; and (3) Legionnaires’ disease caused by L. pneumophila.
Tepadina® (Thiotepa for injection, BP) is indicated in combination with other chemotherapeutic products as part of a high-dose chemotherapy (HDCT) consolidation regimen followed by autologous stem cell transplantation (ASCT) for adult patients with central nervous system (CNS) lymphoma
For complete prescribing information, please consult the Product Monograph.
Intramuscular injection of Toradol® (ketorolac tromethamine) is indicated for:
- The short-term management (not to exceed 2 days) of moderate to severe acute pain, including pain following major abdominal, orthopaedic and gynaecological operative procedures.
For more information, please consult the Product Monograph.